RBC Europe’s iShares Biotechnology ETF IBB Stock Holding History

RBC Europe’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$59K	Hold	500	–	–	﹤0.01%	313
2022 Q1	$65K	Hold	500	–	–	﹤0.01%	324
2021 Q4	$76K	Buy	500 +25	+5%	+$3.87K	﹤0.01%	313
2021 Q3	$76.8K	Hold	475	–	–	﹤0.01%	474
2021 Q2	$77.7K	Hold	475	–	–	﹤0.01%	485
2021 Q1	$71.5K	Hold	475	–	–	﹤0.01%	475
2020 Q4	$72K	Hold	475	–	–	﹤0.01%	437
2020 Q3	$64.3K	Buy	475 +370	+352%	+$50.2K	﹤0.01%	415
2020 Q2	$14.4K	Hold	105	–	–	﹤0.01%	688
2020 Q1	$11.3K	Hold	105	–	–	﹤0.01%	678
2019 Q4	$12.7K	Hold	105	–	–	﹤0.01%	751
2019 Q3	$10.4K	Hold	105	–	–	﹤0.01%	782
2019 Q2	$11.5K	Hold	105	–	–	﹤0.01%	778
2019 Q1	$11.7K	Hold	105	–	–	﹤0.01%	777
2018 Q4	$10.1K	Hold	105	–	–	﹤0.01%	782
2018 Q3	$12.8K	Hold	105	–	–	﹤0.01%	792
2018 Q2	$11.5K	Hold	105	–	–	﹤0.01%	821
2018 Q1	$11.2K	Sell	105 -495	-83%	-$54.9K	﹤0.01%	813
2017 Q4	$64.1K	Hold	600	–	–	0.01%	426
2017 Q3	$66.7K	Buy	+600	New	+$64.1K	0.01%	427

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RBC Europe's IBB Position: Q2 2022 in Review

RBC Europe held its iShares Biotechnology ETF (IBB) position steady in Q2 2022 at 500 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

RBC Europe first reported a position in IBB in Q3 2017 and has held it in 20 quarters since. The position peaked at $77.7K in Q2 2021. 859 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

RBC Europe held 500 shares of iShares Biotechnology ETF worth $59K as of Q2 2022.
RBC Europe left its iShares Biotechnology ETF share count unchanged in Q2 2022.
iShares Biotechnology ETF made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #313 holding.
RBC Europe first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 20 quarters since.
RBC Europe's iShares Biotechnology ETF position peaked at $77.7K in Q2 2021.
859 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.